Literature DB >> 8898206

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.

R A Ophoff1, G M Terwindt, M N Vergouwe, R van Eijk, P J Oefner, S M Hoffman, J E Lamerdin, H W Mohrenweiser, D E Bulman, M Ferrari, J Haan, D Lindhout, G J van Ommen, M H Hofker, M D Ferrari, R R Frants.   

Abstract

Genes for familial hemiplegic migraine (FHM) and episodic ataxia type-2 (EA-2) have been mapped to chromosome 19p13. We characterized a brain-specific P/Q-type Ca2+ channel alpha1-subunit gene, CACNL1A4, covering 300 kb with 47 exons. Sequencing of all exons and their surroundings revealed polymorphic variations, including a (CA)n-repeat (D19S1150), a (CAG)n-repeat in the 3'-UTR, and different types of deleterious mutations in FHM and EA-2. In FHM, we found four different missense mutations in conserved functional domains. One mutation has occurred on two different haplotypes in unrelated FHM families. In EA-2, we found two mutations disrupting the reading frame. Thus, FHM and EA-2 can be considered as allelic channelopathies. A similar etiology may be involved in common types of migraine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898206     DOI: 10.1016/s0092-8674(00)81373-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  470 in total

Review 1.  Automated mutation analysis.

Authors:  D Ravine
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Alternative splicing of a short cassette exon in alpha1B generates functionally distinct N-type calcium channels in central and peripheral neurons.

Authors:  Z Lin; Y Lin; S Schorge; J Q Pan; M Beierlein; D Lipscombe
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

3.  Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit.

Authors:  K Jun; E S Piedras-Rentería; S M Smith; D B Wheeler; S B Lee; T G Lee; H Chin; M E Adams; R H Scheller; R W Tsien; H S Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 4.  Ion channels and neurology.

Authors:  S M Zuberi; M G Hanna
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

Review 5.  Ion channel genes and human neurological disease: recent progress, prospects, and challenges.

Authors:  E C Cooper; L Y Jan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 6.  Molecular determinants of inactivation in voltage-gated Ca2+ channels.

Authors:  S Hering; S Berjukow; S Sokolov; R Marksteiner; R G Weiss; R Kraus; E N Timin
Journal:  J Physiol       Date:  2000-10-15       Impact factor: 5.182

7.  Ion channels in health and disease. 83rd Boehringer Ingelheim Fonds International Titisee Conference.

Authors:  B A Niemeyer; L Mery; C Zawar; A Suckow; F Monje; L A Pardo; W Stuhmer; V Flockerzi; M Hoth
Journal:  EMBO Rep       Date:  2001-07       Impact factor: 8.807

8.  Temperature-modulated array high-performance liquid chromatography.

Authors:  A Premstaller; W Xiao; H Oberacher; M O'Keefe; D Stern; T Willis; C G Huber; P J Oefner
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

9.  Modulation of slow inactivation in class A Ca2+ channels by beta-subunits.

Authors:  S Sokolov; R G Weiss; E N Timin; S Hering
Journal:  J Physiol       Date:  2000-09-15       Impact factor: 5.182

Review 10.  Unraveling monogenic channelopathies and their implications for complex polygenic disease.

Authors:  J Jay Gargus
Journal:  Am J Hum Genet       Date:  2003-03-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.